MEMS Journal -- The Largest MEMS Publication in the World

Search

WEEKLY NEWSLETTER

  • Our free weekly newsletter brings you the top MEMS stories from 9,200+ sources worldwide. Our newsletter also reports on the most vital newly-granted patents in the MEMS industry. Subscribe today and join our 34,800+ subscribers by clicking the link below.

    Subscribe
    Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon

Services










Contact us

  • MEMS Journal, Inc.
    2000 Town Center
    Suite 1900
    Southfield, Michigan 48075
    USA
    248.792.9618 (office)

Recent Posts

  • Science Corporation acquires MEMSCAP's North Carolina MEMS fabrication facility
  • MEMS maker Pearl Semiconductor announces single-die technology for timing solutions
  • MEMSCAP launches restructuring of US operations, explores fab-lite plan
  • MEMS and IC foundry SilTerra to invest $150 million to increase fabrication capacity
  • MEMS foundry Silex Microsystems acquires 200mm wafer fab from Elmos Semiconductor
  • RF MEMS maker Sofant Technologies signs $8.2 million contract with European Space Agency
  • MEMS maker UltraSense developing smart HMI solutions
  • MEMS gas sensor maker Lelantos raises seed-stage funds
  • Omnitron Sensors raises $2.4 million to build next-generation MEMS based capacitive and optical sensors
  • Glass fabrication solutions for MEMS and RF applications

Contact emails

  • Consulting
  • Editor
  • Events
  • IP Services
  • Market Research
  • Marketing
  • Recruiting

Medical MEMS: SQZ Biotech raises $65 million to develop cell therapies

200520 SQZ logoSQZ Biotechnologies (SQZ), a clinical stage cell therapy company developing innovative treatments for multiple therapeutic areas, announced this week the completion of a $65 million Series D preferred stock financing. The round was led by Temasek with participation from another new large, US-based fund as well as additional participation from existing investors, including GV, Illumina Ventures, Invus, JDRF T1D Fund, NanoDimension, and Polaris Partners. The company also announced the expansion of its cellular vaccine platform, currently in trial for oncology, into infectious diseases, and development of a point-of-care system to potentially generate patient product directly at treatment centers.

Continue reading "Medical MEMS: SQZ Biotech raises $65 million to develop cell therapies" »

May 21, 2020 at 12:15 AM | Permalink | Comments (0)

Sensera's MEMS devices mimic human organs through bioengineering

180329 Sensera logoSensera is adapting its MEMS technology for new applications in bioengineering. The company's MEMS technology is now being used at Harvard University for the creation of microfluidic devices which mimic the functions of living human organs, including the lung, intestine, kidney, skin, bone marrow and blood-brain barrier. "Sensera is a key partner providing critical microdevice component fabrication, which enables our growing applications in precision medicine and personalized health," said Dr. Richard Novak, Senior Staff Engineer at Harvard University's Wyss Institute for Biologically Inspired Engineering. "These microchips, called "organs-on-chips", offer a potential alternative to traditional animal testing. Each organ-on-chip comprises a polymeric membrane that contains hollow channels lined by living human cells."

Continue reading "Sensera's MEMS devices mimic human organs through bioengineering" »

June 05, 2018 at 01:29 PM | Permalink | Comments (0)

Medical MEMS: Biolinq raises $10 million for painless blood glucose sensors

171128 Biolinq logoBiolinq announced this week the close of a $10 million Series A financing led by M Ventures, in collaboration with Hikma Ventures. Biolinq is a digital health company with a unique, wirelessly-enabled biosensor patch that is capable of continuously monitoring multiple biomarkers. Grey Sky Venture Partners, Three Leaf Ventures, LifeSci Venture Partners and a group of high-net-worth individuals specialized in the diabetes field are also contributing to the round. Biolinq's first commercial product, a unique minimally-invasive technology, will allow patients with diabetes to continuously monitor their blood glucose without the pain and hassle of traditional continuous glucose monitoring (CGM) systems.

Continue reading "Medical MEMS: Biolinq raises $10 million for painless blood glucose sensors" »

November 28, 2017 at 03:14 PM | Permalink | Comments (0)

Tronics opens MEMS production facility for healthcare applications

170420 Tronics logoTronics, a TDK Group company that designs and manufactures nano and microsystems, has announced the opening of a MEMS production facility located in Addison, Texas, near Dallas.  The fab expands Tronics' MEMS development and manufacturing capabilities in North America.  Tronics aims to utilize the full control of its manufacturing assets to provide custom MEMS services tailored for healthcare applications such as diagnostic chips, microfluidics, lab-on-chips, and also suitable for chemical sensors, infrared sensors, and optical grating devices needed in the industrial field.

Continue reading "Tronics opens MEMS production facility for healthcare applications" »

April 20, 2017 at 04:56 PM | Permalink | Comments (0)

Tronics rides the medical MEMS wave

140522 HB picture for Tronics (cropped 2)According to our research, the MEMS market for medical applications is currently approximately $2.1 billion, and is projected to grow at double digit rates for the next decade.  Since MEMS based motion sensors for consumer applications are rapidly getting commoditized, medical MEMS may represent the most lucrative emerging opportunity for MEMS device designers and manufacturers.  Tronics, a MEMS foundry services provider, is already manufacturing MEMS devices for several key players in the medical industry.  The company says that it has made this market segment a priority and wants to grow its medical business to more than $20 million annually within three to five years.  We recently spoke with Herve Borrel, Tronics’ President of North America.

Continue reading "Tronics rides the medical MEMS wave" »

May 22, 2014 at 02:05 PM | Permalink | Comments (0)

BioMEMS: navigating the medical device FDA approval process

by David DiPaola
Managing Director, DiPaola Consulting

121127 David DiPaola photoWith major advances in MEMS and nanotechnology and their proliferation into medicine, it is important to have a working knowledge of the critical steps in obtaining U.S. Food and Drug Administration (FDA) approval for commercialization.  An understanding of the core elements and expedited review opportunities for medical devices provides entrepreneurs a key advantage in decision making, development and commercialization for the shortest time to market.

Many MEMS products intended for use with humans are considered medical devices under the FDA approval process. This includes products for diagnostics, monitoring, surgical and therapeutic applications.  For a manufacturer to market or commercially distribute a medical device, it must first comply with the regulatory requirements of the FDA.  The critical steps of this process are outlined in the flow chart below.

Continue reading "BioMEMS: navigating the medical device FDA approval process" »

November 27, 2012 at 04:30 PM | Permalink | Comments (1)

ISSYS receives $1.5 million grant for the development of MEMS based pediatric cardiac implants

ISSYSlogoIntegrated Sensing Systems, Inc. (ISSYS) and the University of Michigan announced that they have received a $1.5 million National Institute of Health (NIH) grant titled "Novel Micro-Implant To Measure Intracardiac Pressure In Congenital Heart Patients."  Dr. Martin Bocks, a pediatric cardiologist at the University of Michigan and the project's medical principal investigator, stated that "we are extremely excited to continue working with ISSYS to develop a wireless, implantable pressure sensor for our patients with complex forms of congenital heart disease. This pressure sensing implant has the potential to greatly improve the care we provide to our most complex patients and will provide us with unprecedented opportunities to learn more about their unique physiology."

Continue reading "ISSYS receives $1.5 million grant for the development of MEMS based pediatric cardiac implants" »

February 16, 2012 at 01:12 PM | Permalink | Comments (2)

MEMS and microelectrode technologies for hearing restoration

by John Williamson
Contributing Editor, MEMS Investor Journal

JohnWphotoTwo common types of hearing loss suffered by millions of people worldwide are sensorineural hearing loss and conductive hearing loss.  The former is caused primarily by damage to the cochlea, the snail-shell like structure of the inner ear containing hair cells, the movement of which is interpreted by the brain as sound.   On the other hand, conductive hearing loss relates to problems with conducting sound waves along the route between the outer ear to the middle ear, and may occur along with sensorineural hearing loss.  This article examines MEMS based approaches to improving the ability to hear.

Continue reading "MEMS and microelectrode technologies for hearing restoration" »

November 10, 2011 at 05:53 PM | Permalink | Comments (0)

Bio-Rad acquires QuantaLife's microfluidic technology for $162 million

Biorad Bio-Rad Laboratories, a manufacturer and distributor of life science research and clinical diagnostics products, announced this week that it has acquired QuantaLife, a microfluidic technology startup, for $162 million in cash plus potential future milestone payments.  QuantaLife raised $17.2 million in venture capital financing in December 2010.

Continue reading "Bio-Rad acquires QuantaLife's microfluidic technology for $162 million" »

October 06, 2011 at 06:47 PM | Permalink | Comments (0)

PerkinElmer to acquire microfluidics company Caliper for $600 million

Logo_perkin_elmer PerkinElmer, a global biomedical company, announced this week that it has signed a definitive agreement to acquire Caliper Life Sciences, a Hopkinton, Massachusetts-based firm that specializes in microfluidic technologies for life sciences research, diagnostics and environmental markets, for a total net purchase price of approximately $600 million in cash.  The total purchase price represents a premium of 42% for Caliper Life Sciences shareholders.  "The acquisition of Caliper Life Sciences brings innovative molecular imaging and detection technologies to our portfolio, complementing our world-leading offerings in life science, diagnostics, environmental and food markets," said PerkinElmer's CEO Robert F. Friel.

Continue reading "PerkinElmer to acquire microfluidics company Caliper for $600 million" »

September 08, 2011 at 05:43 PM | Permalink | Comments (0)

»

Sponsors

























































Categories

  • Audio MEMS (21)
  • Automotive MEMS (10)
  • Automotive Sensors (1)
  • BioMEMS (40)
  • CMOS MEMS (1)
  • Energy Harvesting (6)
  • Fabrication Equipment (2)
  • FHE (1)
  • Gas Sensors (3)
  • HMI (1)
  • HMI Sensors (3)
  • Industry Trends (111)
  • Inertial MEMS (45)
  • Internet of Things (3)
  • Medical MEMS (1)
  • MEMS Displays (4)
  • MEMS Manufacturing (92)
  • MEMS Memory (4)
  • MEMS Oscillators (4)
  • MEMS Software (3)
  • MEMS switches (1)
  • MEMS Testing (1)
  • Microfluidics (10)
  • MOEMS (20)
  • PMUTs (1)
  • RF MEMS (30)
  • Sensor Hubs (1)
  • Sensor Networks (1)
  • Wearables (3)
See More